SMTL ID : 7ls9.1

Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein

Coordinates
PDB Format
Method
ELECTRON MICROSCOPY
Oligo State
hetero-3-3-3-mer
Ligands
3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Cerutti, G. et al., Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies. Structure (2021)
Release Date
2021-03-17
Peptides
Spike glycoprotein: ADG
1-57 Fab heavy chain: BEH
1-57 Fab light chain: CFI
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
D
B
G
C
B
H
E
D
H
E
C
L
F
F
I
G